eMAX Health Systems, LLC was established in 2004 to provide independent research and innovative pharmaceutical commercialization support across various segments of the global healthcare system. The eMAX Health Market Access and Health Economics business includes global clinicians and researchers skilled in comparative effectiveness research, market access strategy and account pull-through programs to optimize the value of biopharmaceutical products. Its subsidiary, eMAX Health Patient Access Center helps implement medical policy by managed care organizations to improve patient access to needed treatments. eMAX Health offers independent outcomes monitoring, rebate adjudication, and administrative reporting services, bringing competing interests together to improve health outcomes and lower cost.